Atlas Trials

Study of Radiotherapy Administered in Combination With Ipilimumab in Patients With Unresectable Stage III or Stage IV Advanced Malignant Melanoma

Clinical trial NCT01557114 · TERMINATED

Trial details

NCT number
NCT01557114
Sponsor
Gustave Roussy, Cancer Campus, Grand Paris
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Malignant Melanoma
Start date
2011-03-01
Primary completion
2015-11-01
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.